Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Low Dose Once Daily Oral Iron Treatment of Young Children with Nutritional Iron Deficiency Anemia

Jacquelyn M. Powers, MD, Timothy L. Mccavit, MD, Leah Adix, CCRP, George R. Buchanan, MD

Blood (2015) 126 (23): 2147.

https://doi.org/10.1182/blood.V126.23.2147.2147

Published: 2015

Journal Articles

Accuracy of Administrative Coding for Sickle Cell Disease

Michelle Ting, MD, Shyamli Sinha, MD, Timothy L. McCavit, MD

Blood (2015) 126 (23): 3260.

https://doi.org/10.1182/blood.V126.23.3260.3260

Published: 2015

Journal Articles

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Unresponsive to Oral Iron Therapy

Jacquelyn M. Powers, MD, Mark P. Shamoun, MD, Timothy L. McCavit, MD, Leah Adix, CCRP, George R. Buchanan, MD

Blood (2015) 126 (23): 4552.

https://doi.org/10.1182/blood.V126.23.4552.4552

Published: 2015

Journal Articles

Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis

Ted Wun, MD, Marilyn J. Telen, MD, Lakshmanan Krishnamurti, MD, Timothy L. McCavit, MD, Laura M DeCastro, MD, Henry Flanner, ME, Frans A. Kuypers, PhD, Sandra K. Larkin, MS, Seungshin Rhee, MS, John L. Magnani, PhD, Helen M. Thackray, MD

Blood (2014) 124 (21): 2704.

https://doi.org/10.1182/blood.V124.21.2704.2704

Published: 2014

Journal Articles

Survival into Adulthood in Sickle Cell Disease from the Dallas Newborn Cohort

Melissa D. Mathias, MD, Song Zhang, PhD, Zora R. Rogers, MD, George R. Buchanan, MD, Alecia C. Nero, MD, Timothy L. McCavit, MD MS

Blood (2014) 124 (21): 559.

https://doi.org/10.1182/blood.V124.21.559.559

Published: 2014

Journal Articles

An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia

Timothy L. McCavit, MD, MS, Lakshmanan Krishnamurti, MD, Lewis L. Hsu, MD, PhD, Charles T. Quinn, MD, MS, Isaac Odame, MD, Ofelia A. Alvarez, MD, Catherine Driscoll, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Ted Wun, MD, Marilyn J. Telen, MD, Helen Thackray, MD

Blood (2013) 122 (21): 2206.

https://doi.org/10.1182/blood.V122.21.2206.2206

Published: 2013

Journal Articles

GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease

Marilyn J. Telen, MD, Ted Wun, MD, Timothy L. McCavit, MD, MS, Laura M. De Castro, MD, Lakshmanan Krishnamurti, MD, Sophie Lanzkron, MD, MHS, Lewis L. Hsu, MD, PhD, Wally R. Smith, MD, Seungshin Rhee, MS, John L. Magnani, PhD, Helen Thackray, MD

Blood (2013) 122 (21): 776.

https://doi.org/10.1182/blood.V122.21.776.776

Published: 2013

Journal Articles

Impact of Jaundice On Adults with Sickle Cell Anemia

Alecia C. Nero, MD, Timothy L. McCavit, MD, Leah M. Adix, CCRP, Bonnie L. Davis, RN, Beena S. Mathew, RN, Beverley Adams-Huet, MS, George R. Buchanan, MD

Blood (2012) 120 (21): 4753.

https://doi.org/10.1182/blood.V120.21.4753.4753

Published: 2012

Journal Articles

Quality of Care in Hospitalizations for Sickle Cell Disease in the U.S.: Do Low Patient Volumes Mean Higher Mortality?

Timothy L McCavit, MD, Song Zhang, Ph.D., Chul Ahn, Ph.D., Glenn Flores, M.D., Charles T Quinn, M.D.

Blood (2008) 112 (11): 166.

https://doi.org/10.1182/blood.V112.11.166.166

Published: 2008

NARROW

Low Dose Once Daily Oral Iron Treatment of Young Children with Nutritional Iron Deficiency Anemia

Accuracy of Administrative Coding for Sickle Cell Disease

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Unresponsive to Oral Iron Therapy

Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis

Survival into Adulthood in Sickle Cell Disease from the Dallas Newborn Cohort

An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia

GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease

Impact of Jaundice On Adults with Sickle Cell Anemia

Quality of Care in Hospitalizations for Sickle Cell Disease in the U.S.: Do Low Patient Volumes Mean Higher Mortality?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only